Processa Pharmaceuticals (PCSA) Q4 2024 Earnings

30OctConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-1.18
-0.81
-0.45
-0.08

Details

Expected EPS
-1
Actual EPS
-1.03
Surprise EPS
-0.03
Surprise Percent
+3%

Description

Processa Pharmaceuticals (PCSA) has reported earnings of -1.03 per share for Q4 2024.

0 Comments

Share your thoughts